Global trends in rates of IBD hospitalization examined

Global trends in rates of IBD hospitalization examined

For countries with compounding prevalence of inflammatory bowel disease (IBD; stage 3), hospitalization rates are stable, while they are increasing for countries with accelerating incidence, according to a systematic review and temporal analysis published online July 18 in Clinical Gastroenterology & Hepatology.

Michael J. Buie, from the University of Calgary in Alberta, Canada, and colleagues conducted a of population-based studies reporting hospitalization rates for IBD, Crohn disease (CD), or ulcerative colitis (UC). The average annual percentage change (AAPC) was calculated. Data were stratified by epidemiologic stage of regions: compounding prevalence (stage 3) in North America, Western Europe, and Oceania; accelerating incidence (stage 2) in Asia, Eastern Europe, and Latin America; and emergence (stage 1) in developing countries.

The researchers found that in countries in stage 3, hospitalization rates for a primary diagnosis of IBD, CD, and UC were stable (AAPCs, −0.13, 0.20, and 0.02 percent, respectively). In contrast, in stage 2, hospitalization rates for a primary diagnosis were increasing for IBD, CD, and UC (AAPCs, 4.44, 8.34, and 3.90 percent, respectively). For developing regions in stage 1, there were no population-based studies available.

"With the increasing incidence of IBD in newly industrialized countries in stage 2 (acceleration in incidence), have followed suit," the authors write. "These countries will need to address the increasing burden of IBD to ensure their health care systems optimize medical management with the goal of shifting care from the hospital to the community."

Several authors disclosed financial ties the biopharmaceutical industry.

More information: Abstract/Full Text

Copyright © 2022 HealthDay. All rights reserved.

Citation: Global trends in rates of IBD hospitalization examined (2022, August 18) retrieved 28 January 2023 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Incidence, prevalence of pediatric IBD increasing globally


Feedback to editors